RHN

Practice Better Integrates That Clean Life, Further Empowering Health and Wellness Professionals

Retrieved on: 
Tuesday, December 5, 2023

TORONTO, Dec. 5, 2023 /PRNewswire/ -- Practice Better, the all-in-one practice management software platform for health and wellness professionals, today announced the integration of That Clean Life, the nutrition planning software acquired earlier this year. For the first time, Practice Better customers can seamlessly consolidate nutrition planning into their workflow from within their practice management platform to give them back time and improve client outcomes.

Key Points: 
  • TORONTO, Dec. 5, 2023 /PRNewswire/ -- Practice Better , the all-in-one practice management software platform for health and wellness professionals, today announced the integration of That Clean Life, the nutrition planning software acquired earlier this year.
  • Practice Better is one of the first practice management platforms to integrate nutrition planning functionality, making it easier for practitioners to provide more holistic care.
  • "Acquiring That Clean Life earlier this year was a significant opportunity for Practice Better.
  • The integration of That Clean Life with Practice Better will be a game changer, not only in my business but in the businesses of countless health practitioners using these platforms."

DGAP-News: RHÖN-KLINIKUM Aktiengesellschaft: Dr. Christian Höftberger appointed new CEO of RHÖN-KLINIKUM AG

Retrieved on: 
Thursday, November 5, 2020

At its meeting today, the Supervisory Board of RHN-KLINIKUM AG has unanimously appointed Dr. Christian Hftberger (46) as the new chairman of the Board of Management with immediate effect.

Key Points: 
  • At its meeting today, the Supervisory Board of RHN-KLINIKUM AG has unanimously appointed Dr. Christian Hftberger (46) as the new chairman of the Board of Management with immediate effect.
  • Hftberger, who holds a doctorate in law, has been a member of the Board of Management since
    15 August 2020.
  • Up to 2012 he worked at RHN-KLINIKUM AG, most recently as commercial managing director at the Group's university hospital in Giessen.
  • Dr. Jan Liersch, chairman of the Supervisory Board of RHN-KLINIKUM AG, stated: "With Dr. Christian Hftberger the Supervisory Board has appointed a seasoned hospital expert to this position who knows
    the Company really well.

DGAP-News: RHÖN-KLINIKUM AG concludes the first six months of 2020 with increased revenues - Huge contribution towards fighting COVID-19 pandemic - Strategic partnership with Asklepios

Retrieved on: 
Thursday, August 6, 2020

This was only possible because we were already well prepared for the COVID-19 pandemic at an early stage.

Key Points: 
  • This was only possible because we were already well prepared for the COVID-19 pandemic at an early stage.
  • Apart from the COVID-19 pandemic, the first six months of 2020 were also characterised by the takeover of RHN-KLINIKUM AG by Asklepios Kliniken GmbH & Co. KGaA.
  • Asklepios completed the voluntary public takeover offer to the shareholders of RHN-KLINIKUM AG which was announced on 28th February 2020 and published on 8th April 2020.
  • Dr. Gunther K. Weiss, Operative Member of the Board of Management of RHN-KLINIKUM AG, stated: "The Board of Management of RHN-KLINIKUM AG welcomes the new partnership with Asklepios.

DGAP-News: RHÖN-KLINIKUM Aktiengesellschaft: Management Board of RHÖN-KLINIKUM AG Welcomes New Partnership with Asklepios

Retrieved on: 
Thursday, July 9, 2020

The Management Board of RHN-KLINIKUM AG welcomes the new partnership with Asklepios Kliniken GmbH & Co. KGaA.

Key Points: 
  • The Management Board of RHN-KLINIKUM AG welcomes the new partnership with Asklepios Kliniken GmbH & Co. KGaA.
  • Asklepios and Eugen Mnch now hold 92.58 % of RHN-KLINIKUM AG shares with voting rights.
  • RHN-KLINIKUM AG with its five sites providing maximum and intermediate medical care will continue to remain an independent enterprise - under the roof of the Asklepios Group.
  • RHN and Asklepios will strategically complement each other on several levels and be strong together in the future.

DGAP-News: Asklepios Kliniken: Asklepios successfully acquires RHÖN-KLINIKUM AG

Retrieved on: 
Thursday, July 9, 2020

Asklepios Kliniken GmbH & Co. KGaA successfully concluded the voluntary public takeover offer to the shareholders of RHN-KLINIKUM AG as part of its objective of creating a strategic partnership.

Key Points: 
  • Asklepios Kliniken GmbH & Co. KGaA successfully concluded the voluntary public takeover offer to the shareholders of RHN-KLINIKUM AG as part of its objective of creating a strategic partnership.
  • In total, this gives Asklepios a share in the voting rights of approximately 84.98%.
  • As announced in February, Asklepios will contribute these shares to the new joint venture established together with RHN founder Eugen Mnch.
  • RHN-KLINIKUM AG will remain an independent company within the Asklepios group after the transaction has been concluded.

DGAP-News: Asklepios Kliniken: Joint venture between Asklepios and RHÖN founder Eugen Münch cleared by Bundeskartellamt

Retrieved on: 
Tuesday, May 26, 2020

On May 26, 2020, Asklepios Kliniken GmbH & Co. KGaA obtained approval from the Bundeskartellamt to pool the joint shares in RHN-KLINIKUM AG (RKA) held with RHN founder Eugen Mnch in a joint venture and for the voluntary public takeover offer for all outstanding shares in RKA.

Key Points: 
  • On May 26, 2020, Asklepios Kliniken GmbH & Co. KGaA obtained approval from the Bundeskartellamt to pool the joint shares in RHN-KLINIKUM AG (RKA) held with RHN founder Eugen Mnch in a joint venture and for the voluntary public takeover offer for all outstanding shares in RKA.
  • Eugen Mnch, RHN's founder and Chairman of the Supervisory Board, added, "In the present situation, RHN is facing major challenges along with the sector as a whole.
  • At the end of February, Asklepios and Eugen Mnch had announced their decision to pool their shares in RKA in a joint venture.
  • Mnch is contributing approximately 7.6% of RHN shares to the joint venture through HCM SE, which he controls, and is, together with his wife, selling approximately 12.4% of RHN shares to Asklepios, which will likewise contribute these shares to the joint venture.